Skip to main content
. 2024 Feb 23;16(1):25–37. doi: 10.4047/jap.2024.16.1.25

Table 2. Results of the statistical analysis of monoclinic phase volume values (%).

Surface Treatment Sintering Type Total
C S SS
CL MN ± SD 0.90 ± 0.64 0.18 ± 0.38 0.20 ± 0.43 0.43 ± 0.59
MD (Min-Max) 1.14ABC (0-1.68) 0A (0-0.92) 0A (0-1.02) 0a (0-1.68)
P MN ± SD 2.01 ± 0.77 0.69 ± 0.90 0.65 ± 0.85 1.12 ± 1.03
MD (Min-Max) 2.19ABC (0-2.67) 0AB (0-1.89) 0AB (0-1.96) 1.52a (0-2.67)
G MN ± SD 0 ± 0 6.07 ± 13.02 0 ± 0 2.02 ± 7.81
MD (Min-Max) 0A (0-0) 0A (0-35.51) 0A (0-0) 0a (0-35.51)
GP MN ± SD 8.63 ± 1.07 6.56 ± 0.86 3.16 ± 2.76 6.12 ± 2.86
MD (Min-Max) 8.81C (6.56-9.77) 6.32BC (5.75-8.13) 4.72ABC (0-6.27) 6.37b (0-9.77)
GG MN ± SD 7.07 ± 11.55 6.17 ± 10.30 11.46 ± 24.17 8.23 ± 16.16
MD (Min-Max) 0ABC (0-28.21) 0AB (0-26.86) 0AB (0-58.25) 0a (0-58.25)
Total MN ± SD 3.72 ± 6.10 3.93 ± 7.70 3.10 ± 11.31
MD (Min-Max) 1.291 (0-28.21) 012 (0-35.51) 02 (0-58.25)

*MN ± SD: Mean ± Standard Deviation, MD (Min-Max): Median (Minimum-Maximum).

**The same capital letters indicate no difference between sintering × surface treatment type interaction, whereas the same small letters in the same column indicate no difference between the surface treatment groups. The same numbers in the same row indicate no difference between the type of sintering program.